- Home
- IMCR vs PSNY Comparison
IMCR vs PSNY Comparison
Compare IMCR & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- PSNY
- Stock Information
- Founded
- IMCR 2008
- PSNY 2017
- Country
- IMCR United Kingdom
- PSNY Sweden
- Employees
- IMCR N/A
- PSNY N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- PSNY Auto Manufacturing
- Sector
- IMCR Health Care
- PSNY Consumer Discretionary
- Exchange
- IMCR Nasdaq
- PSNY Nasdaq
- Market Cap
- IMCR 1.7B
- PSNY 1.8B
- IPO Year
- IMCR 2021
- PSNY N/A
- Fundamental
- Price
- IMCR $37.97
- PSNY $0.56
- Analyst Decision
- IMCR Buy
- PSNY Hold
- Analyst Count
- IMCR 9
- PSNY 2
- Target Price
- IMCR $67.00
- PSNY $1.25
- AVG Volume (30 Days)
- IMCR 270.5K
- PSNY 7.8M
- Earning Date
- IMCR 11-06-2025
- PSNY 09-03-2025
- Dividend Yield
- IMCR N/A
- PSNY N/A
- EPS Growth
- IMCR N/A
- PSNY N/A
- EPS
- IMCR N/A
- PSNY N/A
- Revenue
- IMCR $379,590,000.00
- PSNY $2,547,619,000.00
- Revenue This Year
- IMCR $30.11
- PSNY $82.42
- Revenue Next Year
- IMCR $8.89
- PSNY $47.97
- P/E Ratio
- IMCR N/A
- PSNY N/A
- Revenue Growth
- IMCR 28.11
- PSNY 24.82
- 52 Week Low
- IMCR $23.15
- PSNY $0.50
- 52 Week High
- IMCR $39.33
- PSNY $1.42
- Technical
- Relative Strength Index (RSI)
- IMCR 68.17
- PSNY 28.23
- Support Level
- IMCR $34.30
- PSNY $0.50
- Resistance Level
- IMCR $38.17
- PSNY $0.58
- Average True Range (ATR)
- IMCR 1.54
- PSNY 0.06
- MACD
- IMCR 0.59
- PSNY -0.02
- Stochastic Oscillator
- IMCR 96.54
- PSNY 13.54
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.